Detalles de la búsqueda
1.
Reproducible Reporting of the Collection and Evaluation of Annotations for Artificial Intelligence Models.
Mod Pathol
; 37(4): 100439, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38286221
2.
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research.
Histopathology
; 84(6): 915-923, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38433289
3.
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Mod Pathol
; 36(1): 100009, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788064
4.
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer.
Breast Cancer Res Treat
; 193(2): 437-444, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397078
5.
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Mod Pathol
; 34(12): 2130-2140, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218258
6.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
; 250(5): 667-684, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32129476
7.
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Mod Pathol
; 33(3): 354-366, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31534203
8.
Interalveolar pore morphology in (pre-)COPD stages and associations with small airways.
Eur Respir J
; 63(2)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423590
9.
Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Histopathology
; 73(6): 923-932, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30168167
10.
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients.
BMC Cancer
; 16: 123, 2016 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26892682
11.
Adult suprapatellar pleiomorphic rhabdomyosarcoma with jejunal metastasis causing intussusception: a case report.
Acta Chir Belg
; 116(6): 376-378, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27426662
12.
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Lancet Oncol
; 15(4): 406-14, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24636208
13.
A Color-conscious Diagnosis.
Clin Infect Dis
; 69(7): 1259-1261, 2019 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31517985
14.
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
Breast Cancer Res
; 14(1): R34, 2012 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22353773
15.
Development of Training Materials for Pathologists to Provide Machine Learning Validation Data of Tumor-Infiltrating Lymphocytes in Breast Cancer.
Cancers (Basel)
; 14(10)2022 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626070
16.
Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis.
NPJ Breast Cancer
; 8(1): 79, 2022 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790747
17.
Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms.
J Med Imaging (Bellingham)
; 9(4): 047501, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35911208
18.
External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices.
Cancers (Basel)
; 14(15)2022 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35954426
19.
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.
J Natl Cancer Inst
; 113(12): 1733-1743, 2021 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34097070
20.
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group.
Cancers (Basel)
; 13(19)2021 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638394